Personal information

Countries

United Kingdom

Activities

Collapse all

Employment (2)

University of Glasgow: Glasgow, GB

Employment
Source: check_circle
University of Glasgow

Queen Elizabeth University Hospital: Glasgow, Glasgow, GB

2013-02-01 to present | Consultant Gastroenterologist (Gastroenterology)
Employment
Source: Self-asserted source
Jonathan Macdonald

Works (28)

Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy

Inflammatory Bowel Diseases
2023-08-23 | Journal article
DOI: 10.1093/ibd/izad174
Part of ISSN: 1078-0998
Part of ISSN: 1536-4844
Contributors: Emily Brownson; Jayne Saunders; Aleksandra Jatkowska; Bernadette White; Konstantinos Gerasimidis; John Paul Seenan; Jonathan Macdonald
Source: Self-asserted source
Jonathan Macdonald

Development and Validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance

Journal of Crohn's and Colitis
2023-04-02 | Journal article
DOI: 10.1093/ecco-jcc/jjad063
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: Aleksandra Jatkowska; Bernadette White; Ben Nichols; Vaios Svolos; Konstantinos Gkikas; Richard Hansen; richard russell; Daniel Gaya; Emily Brownson; John Paul Seenan et al.
Source: Self-asserted source
Jonathan Macdonald

Implications for sequencing of biologic therapy and choice of second <scp>anti‐TNF</scp> in patients with inflammatory bowel disease: results from the <scp>IMmunogenicity</scp> to Second <scp>Anti‐TNF</scp> therapy (<scp>IMSAT</scp>) therapeutic drug monitoring study

Alimentary Pharmacology &amp; Therapeutics
2022-10 | Journal article | Author
DOI: 10.1111/apt.17170
Part of ISSN: 0269-2813
Part of ISSN: 1365-2036
Contributors: Neil Chanchlani; Simeng Lin; Marcus KH Auth; Chai Leng Lee; Helena Robbins; Shi Looi; Senthil V. Murugesan; Tom Riley; Cathryn Preston; Sophie Stephenson et al.
Source: Self-asserted source
Jonathan Macdonald

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

The Lancet Infectious Diseases
2022-08 | Journal article
DOI: 10.1016/s1473-3099(22)00271-7
Part of ISSN: 1473-3099
Contributors: Alasdair P S Munro; Shuo Feng; Leila Janani; Victoria Cornelius; Parvinder K Aley; Gavin Babbage; David Baxter; Marcin Bula; Katrina Cathie; Krishna Chatterjee et al.
Source: Self-asserted source
Jonathan Macdonald

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.

Nature communications
2022-03 | Journal article
DOI: 10.1038/s41467-022-28517-z
PMID: 35296643
PMC: PMC8927425
Contributors: Lin S; Kennedy NA; Saifuddin A; Sandoval DM; Reynolds CJ; Seoane RC; Kottoor SH; Pieper FP; Lin KM; Butler DK et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine
2022-02 | Journal article
DOI: 10.1016/s2213-2600(21)00409-4
Part of ISSN: 2213-2600
Contributors: Seth Toback; Eva Galiza; Catherine Cosgrove; James Galloway; Anna L Goodman; Pauline A Swift; Sankarasubramanian Rajaram; Alison Graves-Jones; Jonathan Edelman; Fiona Burns et al.
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 3)‎

Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic

Frontline Gastroenterology
2022-01 | Journal article
DOI: 10.1136/flgastro-2021-101805
Part of ISSN: 2041-4137
Part of ISSN: 2041-4145
Contributors: Shahida Din; Daniel Gaya; Jochen Kammermeier; Professor Chris Lamb; Jonathan Macdonald; Gordon Moran; Gareth Parkes; Richard Pollok; Shaji Sebastian ; Jonathan P Segal et al.
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 2)‎

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

The Lancet
2021 | Journal article
DOI: 10.1016/S0140-6736(20)32661-1
EID:

2-s2.0-85097463811
Contributors: Voysey, M.; Clemens, S.A.C.; Madhi, S.A.; Weckx, L.Y.; Folegatti, P.M.; Aley, P.K.; Angus, B.; Baillie, V.L.; Barnabas, S.L.; Bhorat, Q.E. et al.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.

Lancet (London, England)
2021-12 | Journal article
DOI: 10.1016/s0140-6736(21)02717-3
PMID: 34863358
PMC: PMC8639161
Contributors: Munro APS; Janani L; Cornelius V; Aley PK; Babbage G; Baxter D; Bula M; Cathie K; Chatterjee K; Dodd K et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central
grade
Preferred source (of 2)‎

Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients.

Journal of Crohn's & colitis
2021-09 | Journal article
DOI: 10.1093/ecco-jcc/jjab153
PMID: 34473254
Contributors: Chanchlani N; Lin S; Chee D; Hamilton B; Nice R; Zehra A; Bewshea C; Cipriano B; Derikx LAAP; Dunlop A et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central
grade
Preferred source (of 2)‎

Crohn's disease of the gallbladder.

BMJ case reports
2021-09 | Journal article
DOI: 10.1136/bcr-2021-243579
PMID: 34551912
Contributors: Scott C; Patel A; Maka N; MacDonald JC
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central
grade
Preferred source (of 2)‎

Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease.

Nutrients
2021-08 | Journal article
DOI: 10.3390/nu13082899
PMID: 34445056
PMC: PMC8398806
Contributors: Steell L; Gray SR; Russell RK; MacDonald J; Seenan JP; Wong SC; Gaya DR
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central
grade
Preferred source (of 2)‎

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.

The New England journal of medicine
2021-06 | Journal article
DOI: 10.1056/nejmoa2107659
PMID: 34192426
PMC: PMC8262625
Contributors: Heath PT; Galiza EP; Baxter DN; Boffito M; Browne D; Burns F; Chadwick DR; Clark R; Cosgrove C; Galloway J et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.

Gut
2021-04 | Journal article
DOI: 10.1136/gutjnl-2021-324789
PMID: 33903149
PMC: PMC8076631
Contributors: Kennedy NA; Lin S; Goodhand JR; Chanchlani N; Hamilton B; Bewshea C; Nice R; Chee D; Cummings JF; Fraser A et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central
grade
Preferred source (of 2)‎

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.

Gut
2021-03 | Journal article
DOI: 10.1136/gutjnl-2021-324388
PMID: 33753421
PMC: PMC7992387
Contributors: Kennedy NA; Goodhand JR; Bewshea C; Nice R; Chee D; Lin S; Chanchlani N; Butterworth J; Cooney R; Croft NM et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central
grade
Preferred source (of 2)‎

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines

2021-03 | Preprint
DOI: 10.1101/2021.03.25.21254335
OTHER-ID:

PPR304138
Contributors: Kennedy NA; Lin S; Goodhand JR; Chanchlani N; Hamilton B; Bewshea C; Nice R; Chee D; Cummings JF; Fraser A et al.
Source: Self-asserted source
Jonathan Macdonald via Europe PubMed Central

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Lancet (London, England)
2021-02-19 | Journal article
DOI: 10.1016/s0140-6736(21)00432-3
PMID: 33617777
PMC: PMC7894131
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 2)‎

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.

The lancet. Gastroenterology & hepatology
2021-02-02 | Journal article
DOI: 10.1016/s2468-1253(21)00016-9
PMID: 33545083
PMC: PMC7906670
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 2)‎

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.

The lancet. Gastroenterology & hepatology
2021-01-26 | Journal article
DOI: 10.1016/s2468-1253(21)00024-8
PMID: 33508241
PMC: PMC7834976
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 2)‎

Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease—new insights into dietary disease triggers

Alimentary Pharmacology and Therapeutics
2020 | Journal article
DOI: 10.1111/apt.15695
EID:

2-s2.0-85082956222

Part of ISBN:

13652036 02692813
Contributors: Logan, M.; Gkikas, K.; Svolos, V.; Nichols, B.; Milling, S.; Gaya, D.R.; Seenan, J.P.; Macdonald, J.; Hansen, R.; Ijaz, U.Z. et al.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

Muscle deficits with normal bone microarchitecture and geometry in young adults with well-controlled childhood-onset Crohn's disease

European Journal of Gastroenterology and Hepatology
2020 | Journal article
DOI: 10.1097/MEG.0000000000001838
EID:

2-s2.0-85094932025

Part of ISBN:

14735687 0954691X
Contributors: Steell, L.; Johnston, B.A.; Dewantoro, D.; Foster, J.E.; Gaya, D.R.; MacDonald, J.; McMillan, M.; Russell, R.K.; Seenan, J.P.; Ahmed, S.F. et al.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis

Therapeutic Advances in Musculoskeletal Disease
2020 | Journal article
DOI: 10.1177/1759720X20904850
EID:

2-s2.0-85079243096

Part of ISBN:

17597218 1759720X
Contributors: Perry, M.; Abdullah, A.; Frleta, M.; MacDonald, J.; McGucken, A.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.

Journal of gastroenterology and hepatology
2020-12-30 | Journal article
DOI: 10.1111/jgh.15390
PMID: 33381875
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 2)‎

Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic

Frontline Gastroenterology
2020-09-30 | Journal article
DOI: 10.1136/flgastro-2020-101563
Part of ISSN: 2041-4137
Part of ISSN: 2041-4145
Source: Self-asserted source
Jonathan Macdonald
grade
Preferred source (of 2)‎

Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

Journal of Crohn's and Colitis
2019 | Journal article
DOI: 10.1093/ecco-jcc/jjz042
EID:

2-s2.0-85072380935

Part of ISBN:

18764479 18739946
Contributors: Plevris, N.; Chuah, C.S.; Allen, R.M.; Arnott, I.D.; Brennan, P.N.; Chaudhary, S.; Churchhouse, A.M.D.; Din, S.; Donoghue, E.; Gaya, D.R. et al.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

Whipple's disease-historical insights and contemporary perspectives

Gastrointestinal Nursing
2011 | Journal article
DOI: 10.12968/gasn.2011.9.10.34
EID:

2-s2.0-84255192667

Part of ISBN:

14795248
Contributors: MacDonald, J.; Leeds, J.S.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

Small bowel lymphangiectasia and angiodysplasia: A positive association; Novel clinical marker or shared pathophysiology?

Journal of Clinical Gastroenterology
2010 | Journal article
DOI: 10.1097/MCG.0b013e3181dd9c3f
EID:

2-s2.0-77957592154

Part of ISBN:

01920790
Contributors: MacDonald, J.; Porter, V.; Scott, N.W.; McNamara, D.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier

Negative capsule endoscopy in patients with obscure GI bleeding predicts low rebleeding rates

Gastrointestinal Endoscopy
2008 | Journal article
DOI: 10.1016/j.gie.2008.06.054
EID:

2-s2.0-56349107000

Part of ISBN:

00165107
Contributors: Macdonald, J.; Porter, V.; McNamara, D.
Source: Self-asserted source
Jonathan Macdonald via Scopus - Elsevier
How many people are using ORCID?